The complex role of serotonin and 5-HT receptors in chronic pain

Behavioural Pharmacology

Volumn 22, Issue 5-6, 2011, Pages 390-404

  Bardin, Laurent ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 hydroxytryptamine; 5 hydroxytryptamine receptors; chronic pain; descending inhibition or facilitation; peripheral

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,N DIMETHYL N [1 METHYL 3 (4 METHYL 1 PIPERIDINYL)PROPYL]BENZENESULFONAMIDE; 4 AMINOBUTYRIC ACID; BEFIRADOL; CLOMIPRAMINE; DOLASETRON MESILATE; MORPHINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; TRAMADOL; VENLAFAXINE;

ALLODYNIA; CHRONIC PAIN; DESENSITIZATION; DRUG POTENTIATION; ELECTROPHYSIOLOGY; FACILITATION; GABAERGIC SYSTEM; HUMAN; HYPERALGESIA; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SPINAL CORD DORSAL HORN;

ANIMALS; CHRONIC PAIN; HUMANS; POSTERIOR HORN CELLS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS;

EID: 80051953574     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328349aae4     Document Type: Review

References (212)

1. Abbott FV, Hong Y, Blier P (1996). Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 35:99-110.
2. Aghajanian GK, Sprouse JS, Sheldon P, Rasmussen K (1990). Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Ann NY Acad Sci 600:93-103.
3. Aira Z, Buesa I, Salgueiro M, Bilbao J, Aguilera L, Zimmermann M, et al. (2010). Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury. Neuroscience 168:831-841.
4. Alhaider AA, Wilcox GL (1993). Differential roles of 5- hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 265:378-385. (Pubitemid 23320985)
5. Alhaider AA, Lei SZ, Wilcox GL (1991). Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 11:1881-1888.
6. Ali Z, Wu G, Kozlov A, Barasi S (1994). The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Brain Res 661:83-90.
7. Ali Z, Wu G, Kozlov A, Barasi S (1996). The role of 5HT3 in nociceptive processing in the rat spinal cord: results from behavioural and electro-physiological studies. Neurosci Lett 208:203-207. (Pubitemid 26141530)
8. Alloui A, Pelissier T, Dubray C, Lavarenne J, Eschalier A (1996). Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol 10:406-407. (Pubitemid 26259798)
9. Anden NE, Olsson Y (1967). 5-hydroxytryptamine in normal and sectioned rat sciatic nerve. Acta Pathol Microbiol Scand 70:537-540.
10. Ardid D, Alloui A, Brousse G, Jourdan D, Picard P, Dubray C, et al. (2001). Potentiation of the antinociceptive effect of clomipramine by a 5-ht1A antagonist in neuropathic pain in rats. Br J Pharmacol 132:1118-1126. (Pubitemid 32241804)
11. Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L (1999). Experimental human muscle pain and muscular hyper-algesia induced by combinations of serotonin and bradykinin. Pain 82:1-8. (Pubitemid 29287080)
12. Bardin L, Colpaert FC (2004). Role of spinal 5-HT1A receptors in morphine analgesia and tolerance in rats. Eur J Pain 8:253-261. (Pubitemid 38596088)
13. Bardin L, Jourdan D, Alloui A, Lavarenne J, Eschalier A (1997). Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats. Brain Res 765:267-272. (Pubitemid 27397622)
14. Bardin L, Lavarenne J, Eschalier A (2000). Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 86:11-18. (Pubitemid 30211697)
15. Bardin L, Tarayre JP, Koek W, Colpaert FC (2001). In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behavio-rally specific analgesia. Eur J Pharmacol 421:109-114. (Pubitemid 32524081)
16. Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC (2003). Profound, non-opioid analgesia produced by the high-efficacy 5-HT1A agonist F 13640 in the formalin model of tonic nociceptive pain. Pharmacology 67:182-194. (Pubitemid 36302469)
17. Bardin L, Assié M-B, Pélissou M, Royer-Urios I, Newman-Tancredi A, Ribet J-P, et al. (2005). Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino] -methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. J Pharmacol Exp Ther 312:1034-1042. (Pubitemid 40293762)
18. Bee LA, Dickenson AH (2007). Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience 147:786-793. (Pubitemid 46990660)
19. Bonaventure P, Nepomuceno D, Kwok A, Chai WY, Langlois X, Hen R, et al. (2002). Reconsideration of 5-hydroxytryptamine (5-HT)7 receptor distribution using [3H]5-carboxamidotryptamine and [3H]8-hydroxy-2-(di-n-propylamino)- tetraline: Analysis in brain of 5-HT1A knockout and 5-HT1A/1B double-knockout mice. J Pharmacol Exp Ther 302:240-248. (Pubitemid 34680444)
20. Bourgoin S, Viguier F, Michot B, Kayser V, Vela JM, Hamon M (2008). 5-HT7 receptor stimulation exerts anti-hyperalgesic effects in rats suffering from neuropathic pain via activation of GABAergic interneurons. Fundam Clin Pharmacol 22:119-131.
21. Brenchat A, Romero L, Garcia M, Pujol M, Burgueno J, Torrens A, et al. (2009). 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 141:239-247.
22. Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sanchez-Arroyos R, et al. (2010). Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain 149:483-494.
23. Bruce JC, Oatway MA, Weaver LC (2002). Chronic pain after clip-compression injury of the rat spinal cord. Exp Neurol 178:33-48. (Pubitemid 35425607)
24. Buritova J, Larrue S, Aliaga M, Besson JM, Colpaert FC (2005). Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study. Eur J Pharmacol 514:121-130. (Pubitemid 40720352)
25. Campbell JN, Meyer RA (2006). Mechanisms of neuropathic pain. Neuron 52:77-92. (Pubitemid 44466361)
26. Cardenas CG, Mar LP, Vysokanov AV, Arnold PB, Cardenas LM, Surmeier DJ, et al. (1999). Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518: (Pt 2):507-523. (Pubitemid 29366746)
27. Cardenas DD, Bryce TN, Shem K, Richards JS, Elhefni H (2004). Gender and minority differences in the pain experience of people with spinal cord injury. Arch Phys Med Rehabil 85:1774-1781. (Pubitemid 39441135)
28. Carstens E (1997). Responses of rat spinal dorsal horn neurons to intracuta-neous microinjection of histamine, capsaicin, and other irritants. J Neuro-physiol 77:2499-2514. (Pubitemid 27209218)
29. Chen JJ, Vasko MR, Wu X, Staeva TP, Baez M, Zgombick JM, et al. (1998). Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther 287:1119-1127. (Pubitemid 29131629)
30. Chen Y, Oatway MA, Weaver LC (2009). Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury. J Neurosci Res 87:418-424.
31. Colpaert FC (1996). System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48:355-402. (Pubitemid 26325802)
32. Colpaert FC (2006). 5-HT1A receptor activation: new molecular and neuroadap-tive mechanisms of pain relief. Curr Opin Investig Drugs 7:40-47. (Pubitemid 43115779)
33. Colpaert FC, Fregnac Y (2001). Paradoxical signal transduction in neurobiolo-gical systems. Mol Neurobiol 24:145-168. (Pubitemid 34066683)
34. Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, et al. (2002). Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology 43:945-958. (Pubitemid 35341231)
35. Colpaert FC, Wu WP, Hao JX, Royer I, Sautel F, Wiesenfeld-Hallin Z, et al. (2004). High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury. Eur J Pharmacol 497:29-33. (Pubitemid 39092424)
36. Colpaert FC, Deseure KR, Stinus L, Adriaensen H (2006a). High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J Pharmacol Exp Ther 316:892-899. (Pubitemid 43131019)
37. Colpaert FC, Hamon M, Wiesenfeld-Hallin Z (2006b). 5-HT1A receptors in chronic pain processing and control. In: Flor H, Kalso E, Dostrovsky JO, editors. Proceedings of the 11th World Congress on Pain. Seattle: IASP Press. pp. 147-154.
38. Conte D, Legg ED, McCourt AC, Silajdzic E, Nagy GG, Maxwell DJ (2005). Transmitter content, origins and connections of axons in the spinal cord that possess the serotonin (5-hydroxytryptamine) 3 receptor. Neuroscience 134:165-173. (Pubitemid 40943643)
39. Cornea-Hebert V, Riad M, Wu C, Singh SK, Descarries L (1999). Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187-209. (Pubitemid 29264253)
40. Crisp T, Stafinsky JL, Spanos LJ, Uram M, Perni VC, Donepudi HB (1991). Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. Gen Pharmacol 22:247-251.
41. Deseure KR, Koek W, Colpaert FC, Adriaensen H (2002). The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain. Eur J Pharmacol 456:51-57. (Pubitemid 35351736)
42. Deseure KR, Koek W, Adriaensen H, Colpaert FC (2003). Continuous administration of the 5-hydroxytryptamine1A agonist (3-chloro-4-fluoro-phenyl)- [4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}piperidin-1-yl] -methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain. J Pharmacol Exp Ther 306:505-514. (Pubitemid 36886147)
43. Deseure KR, Adriaensen HF, Colpaert FC (2004). Effects of the combined continuous administration of morphine and the high-efficacy 5-HT1A agonist, F 13640 in a rat model of trigeminal neuropathic pain. Eur J Pain 8:547-554. (Pubitemid 39504959)
44. Dogrul A, Seyrek M (2006). Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br J Pharmacol 149:498-502.
45. Dogrul A, Ossipov MH, Porreca F (2009). Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 1280:52-59.
46. Doi-Saika M, Tokunaga A, Senba E (1997). Intradermal 5-HT induces Fos expression in rat dorsal horn neurons not via 5-HT3 but via 5-HT2A receptors. Neurosci Res 29:143-149. (Pubitemid 27417519)
47. Doly S, Madeira A, Fischer J, Brisorgueil MJ, Daval G, Bernard R, et al. (2004). The 5-HT2A receptor is widely distributed in the rat spinal cord and mainly localized at the plasma membrane of postsynaptic neurons. J Comp Neurol 472: 496-511. (Pubitemid 38508832)
48. Doly S, Fischer J, Brisorgueil MJ, Verge D, Conrath M (2005). Pre-and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J Comp Neurol 490:256-269. (Pubitemid 41140992)
49. Donovan-Rodriguez T, Urch CE, Dickenson AH (2006). Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain. Neurosci Lett 393:237-242. (Pubitemid 41821115)
50. Ernberg M, Lundeberg T, Kopp S (2000). Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 85:31-39. (Pubitemid 30110741)
51. Eschalier A, Kayser V, Guilbaud G (1989). Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain 36:249-255. (Pubitemid 19045585)
52. Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, et al. (2000). Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12: 2299-2310. (Pubitemid 30497028)
53. Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. (2000). Efficacy and tolerability of tropisetron in primary fibromyalgia-a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl 113:49-54.
54. Fasmer OB, Berge OG, Hole K (1985). Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Different effects in the formalin and tail-flick tests. Neuropharmacology 24:729-734. (Pubitemid 15239047)
55. Fields HL, Heinricher MM (1985). Anatomy and physiology of a nociceptive modulatory system. Philos Trans R Soc Lond B Biol Sci 308:361-374.
56. Fields HL, Basbaum AI, Heinricher MM (2006). Central nervous system mechanisms of pain modulation. In: McMahon S, Koltzenburg M, editors. Wall and Melzack's Textbook of Pain. London: Elsevier. pp. 125-142.
57. Finnerup NB, Sindrup SH, Jensen TS (2007). Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 21:129-136. (Pubitemid 46495946)
58. Fonseca MI, Ni YG, Dunning DD, Miledi R (2001). Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata. Brain Res Mol Brain Res 89:11-19. (Pubitemid 32322730)
59. Gao K, Mason P (2000). Serotonergic Raphe magnus cells that respond to noxious tail heat are not ON or OFF cells. J Neurophysiol 84: 1719-1725.
60. Geranton SM, Fratto V, Tochiki KK, Hunt SP (2008). Descending serotonergic controls regulate inflammation-induced mechanical sensitivity and methyl-CpG-binding protein 2 phosphorylation in the rat superficial dorsal horn. Mol Pain 4:35.
61. Giordano J, Dyche J (1989). Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse. Neuropharmacology 28:423-427. (Pubitemid 19108804)
62. Giordano J, Schultea T (2004). Serotonin 5-HT3 receptor mediation of pain and anti-nociception: implications for clinical therapeutics. Pain Physician 7:141-147. (Pubitemid 38195769)
63. Glaum SR, Proudfit HK, Anderson EG (1988). Reversal of the antinociceptive effects of intrathecally administered serotonin in the rat by a selective 5-HT3 receptor antagonist. Neurosci Lett 95:313-317.
64. Glaum SR, Proudfit HK, Anderson EG (1990). 5-HT3 receptors modulate spinal nociceptive reflexes. Brain Res 510:12-16. (Pubitemid 20060796)
65. Godinez-Chaparro B, Barragan-Iglesias P, Castaneda-Corral G, Rocha-Gonzalez HI, Granados-Soto V (2011). Role of peripheral 5-HT4, 5-HT6, and 5-HT7 receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia. Pain 152:687-697.
66. Goettl VM, Huang Y, Hackshaw KV, Stephens RL Jr. (2002). Reduced basal release of serotonin from the ventrobasal thalamus of the rat in a model of neuropathic pain. Pain 99:359-366. (Pubitemid 35247559)
67. Gold MS, Reichling DB, Shuster MJ, Levine JD (1996). Hyperalgesic agents increase a tetrodotoxin-resistant Na + current in nociceptors. Proc Natl Acad Sci USA 93:1108-1112. (Pubitemid 26052849)
68. Grubb BD, McQueen DS, Iggo A, Birrell GJ, Dutia MB (1988). A study of 5-HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints. Agents Actions 25:216-218. (Pubitemid 19007243)
69. Guilbaud G, Benoist JM, Eschalier A, Gautron M, Kayser V (1989). Evidence for peripheral serotonergic mechanisms in the early sensitization after carrageenin-induced inflammation: electrophysiological studies in the ven-trobasal complex of the rat thalamus using a potent specific antagonist of peripheral 5-HT receptors. Brain Res 502:187-197. (Pubitemid 19266520)
70. Guo W, Robbins MT, Wei F, Zou S, Dubner R, Ren K (2006). Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J Neurosci 26:126-137. (Pubitemid 43089525)
71. Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br J Pharmacol 117:657-666. (Pubitemid 26074120)
72. Hains BC, Everhart AW, Fullwood SD, Hulsebosch CE (2002). Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp Neurol 175:347-362. (Pubitemid 34634289)
73. Hamon M, Bourgoin S (1999). Serotonin and its receptors in pain control. In: Sawynok J, Cowan A, editors. Novel Aspects of Pain Management: Opioids and Beyond. New York: Wiley. pp. 203-228.
74. Hannon J, Hoyer D (2008). Molecular biology of 5-HT receptors. Behav Brain Res 195:198-213.
75. Hashizume H, Kawakami M, Yoshida M, Okada M, Enyo Y, Inomata Y (2007). Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats. Spine 32:315-320. (Pubitemid 46197470)
76. Heinricher MM, Morgan MM, Tortorici V, Fields HL (1994). Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63:279-288. (Pubitemid 24333967)
77. Heinricher MM, McGaraughty S, Tortorici V (2001). Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 85:280-286. (Pubitemid 32062137)
78. Heinricher MM, Tavares I, Leith JL, Lumb BM (2009). Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev 60:214-225.
79. Hensler JG, Kovachich GB, Frazer A (1991). A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144.
80. Hernandez A, Constandil L, Laurido C, Pelissier T, Marchand F, Ardid D, et al. (2004). Venlafaxine-induced depression of wind-up activity in mononeuro-pathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo. Int J Neurosci 114:229-242. (Pubitemid 38173520)
81. Hong Y, Abbott FV (1994). Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63:827-836. (Pubitemid 24360235)
82. Hong Y, Ji H, Wei H (2006). Topical ketanserin attenuates hyperalgesia and inflammation in arthritis in rats. Pain 124:27-33. (Pubitemid 44176190)
83. Hoyer D, Pazos A, Probst A, Palacios JM (1986). Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85-96. (Pubitemid 16046019)
84. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. (1994). VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-204.
85. Huang J, Wang YY, Wang W, Li YQ, Tamamaki N, Wu SX (2008). 5-HT3A receptor subunit is expressed in a subpopulation of GABAergic and enkephalinergic neurons in the mouse dorsal spinal cord. Neurosci Lett 441:1-6.
86. Huang J, Cai Q, Chen Y, Hong Y (2009). Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats. Brain Res 1303:39-47.
87. Huang J, Fan Y, Jia Y, Hong Y (2011). Antagonism of 5-HT(2A) receptors inhibits the expression of pronociceptive mediator and enhances endogenous opioid mechanism in carrageenan-induced inflammation in rats. Eur J Pharmacol 654:33-41.
88. Jarvis MF, Boyce-Rustay JM (2009). Neuropathic pain: models and mechanisms. Curr Pharm Des 15:1711-1716.
89. Jensen TS, Yaksh TL (1986). Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat. Brain Res 363: 114-127. (Pubitemid 16148025)
90. Jeong CY, Choi JI, Yoon MH (2004). Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 502: 205-211. (Pubitemid 39336486)
91. Kanayama M, Hashimoto T, Shigenobu K, Oha F, Yamane S (2005). New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial. J Neurosurg Spine 2:441-446.
92. Kawamata T, Omote K, Toriyabe M,Yamamoto H, Namiki A (2003). The activation of 5-HT3 receptors evokes GABA release in the spinal cord. Brain Res 978:250-255. (Pubitemid 36776647)
93. Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, et al. (2007). Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/-and 5-HTT-/-knock-out male mice. Pain 130:235-248. (Pubitemid 46994702)
94. Kia HK, Miquel MC, Mckernan RM, Laporte AM, Lombard MC, Bourgoin S, et al. (1995). Localization of 5-HT3 receptors in the rat spinal cord: immunohis-tochemistry and in situ hybridization. Neuroreport 6:257-261.
95. Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB (1989). Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain 37:223-227. (Pubitemid 19136151)
96. Kiss I, Degryse AD, Bardin L, Gomez de Segura IA, Colpaert FC (2005). The novel analgesic, F 13640, produces intra-and postoperative analgesia in a rat model of surgical pain. Eur J Pharmacol 523:29-39. (Pubitemid 41562374)
97. Kuner R (2010). Central mechanisms of pathological pain. Nat Med 16: 1258-1266.
98. Kupers R, Frokjaer VG, Naert A, Christensen R, Budtz-Joergensen E, Kehlet H, et al. (2009). A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation. Neuroimage 44:1001-1007.
99. Lanfumey L, Hamon M (2004). 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord 3:1-10.
100. Lang PM, Moalem-Taylor G, Tracey DJ, Bostock H, Grafe P (2006). Activity-dependent modulation of axonal excitability in unmyelinated peripheral rat nerve fibers by the 5-HT(3) serotonin receptor. J Neurophysiol 96:2963-2971. (Pubitemid 44837843)
101. Laporte A-M, Koscielniak T, Ponchant M, Vergé D, Hamon M, Gozlan H (1992). Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse 10:271-281.
102. Lischetzki G, Rukwied R, Handwerker HO, Schmelz M (2001). Nociceptor activation and protein extravasation induced by inflammatory mediators in human skin. Eur J Pain 5:49-57. (Pubitemid 32661927)
103. Liu MY, Su CF, Lin MT (1988). The antinociceptive role of a bulbospinal serotonergic pathway in the rat brain. Pain 33:123-129.
104. Liu XY, Wu SX, Wang YY, Wang W, Zhou L, Li YQ (2005). Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain. Neurosci Lett 375:42-46. (Pubitemid 40139065)
105. Liu FY, Qu XX, Ding X, Cai J, Jiang H, Wan Y, et al. (2010). Decrease in the descending inhibitory 5-HT system in rats with spinal nerve ligation. Brain Res 1330:45-60.
106. Marlier L, Teilhac JR, Cerruti C, Privat A (1991). Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord. Brain Res 550:15-23.
107. Martikainen IK, Hirvonen J, Kajander J, Hagelberg N, Mansikka H, Nagren K, et al. (2007). Correlation of human cold pressor pain responses with 5-HT1A receptor binding in the brain. Brain Res 1172:21-31. (Pubitemid 47417946)
108. Martin-Cora FJ, Pazos A (2004). Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. Br J Pharmacol 141:92-104. (Pubitemid 38241167)
109. Maxwell DJ, Kerr R, Rashid S, Anderson E (2003). Characterisation of axon terminals in the rat dorsal horn that are immunoreactive for serotonin 5-HT3A receptor subunits. Exp Brain Res 149:114-124. (Pubitemid 36286821)
110. McCleane GJ, Suzuki R, Dickenson AH (2003). Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled crossover study. Anesth Analg 97:1474-1478. (Pubitemid 37310150)
111. Meuser T, Pietruck C, Gabriel A, Xie GX, Lim KJ, Palmer PP (2002). 5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons. Life Sci 71:2279-2289. (Pubitemid 35246216)
112. Michaelis M, Vogel C, Blenk KH, Janig W (1997). Algesics excite axotomised afferent nerve fibres within the first hours following nerve transection in rats. Pain 72:347-354. (Pubitemid 27390733)
113. Michaelis M, Vogel C, Blenk KH, Arnarson A, Janig W (1998). Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 18:7581-7587. (Pubitemid 28425839)
114. Millan MJ (1994). Serotonin and pain: Evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain 58:45-61.
115. Millan MJ (1997). The role of descending noradrenergic and serotoninergic pathways in the modulation of nociception: focus on receptor multiplicity. In: Dickenson A, Besson JM, editors. The pharmacology of pain. Berlin: Springer. pp. 385-446.
116. Millan MJ (2002). Descending control of pain. Prog Neurobiol 66:355-474. (Pubitemid 34606906)
117. Millan MJ, Girardon S, Bervoets K (1997). 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: Blockade of its actions by the novel 5-HT2C receptor antagonist SE 206,553. Neuropharmacology 36:743-745. (Pubitemid 27272120)
118. Miquel MC, Emerit MB, Nosjean A, Simon A, Rumajogee P, Brisorgueil MJ, et al. (2002). Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system. Eur J Neurosci 15:449-457. (Pubitemid 35463663)
119. Moalem G, Grafe P, Tracey DJ (2005). Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat. Neuroscience 134:1399-1411. (Pubitemid 41207387)
120. Nadeson R, Goodchild CS (2002). Antinociceptive role of 5-HT1A receptors in rat spinal cord. Br J Anaesth 88:679-684. (Pubitemid 34498597)
121. Nakajima K, Obata H, Ito N, Goto F, Saito S (2009). The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur J Pain 13:441-447.
122. Neubert MJ, Kincaid W, Heinricher MM (2004). Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain 110:158-165. (Pubitemid 38953279)
123. Neumaier JF, Sexton TJ, Yracheta Y, Diaz AM, Brownfield M (2001). Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat 21: 63-73. (Pubitemid 32155392)
124. Nicholson R, Small J, Dixon AK, Spanswick D, Lee K (2003). Serotonin receptor mRNA expression in rat dorsal root ganglion neurons. Neurosci Lett 337:119-122. (Pubitemid 36106571)
125. Nishiyama T (2005). Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. Eur J Pharmacol 516:18-22. (Pubitemid 40780113)
126. Nitanda A, Yasunami N, Tokumo K, Fujii H, Hirai T, Nishio H (2005). Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain. Neurochem Int 47:394-400. (Pubitemid 41242620)
127. Oatway MA, Chen Y, Weaver LC (2004). The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 110:259-268. (Pubitemid 38953291)
128. Obata H, Saito S, Sasaki M, Ishizaki K, Goto F (2001). Antiallodynic effect of intrathecally administered 5-HT(2) agonists in rats with nerve ligation. Pain 90:173-179. (Pubitemid 32146571)
129. Obata H, Saito S, Sasaki M, Goto F (2002). Possible involvement of a muscarinic receptor in the anti-allodynic action of a 5-HT2 receptor agonist in rats with nerve ligation injury. Brain Res 932:124-128. (Pubitemid 34241602)
130. Obata H, Saito S, Sakurazawa S, Sasaki M, Usui T, Goto F (2004). Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury. Pain 108:163-169. (Pubitemid 38251686)
131. Okamoto K, Imbe H, Morikawa Y, Itoh M, Sekimoto M, Nemoto K, et al. (2002). 5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats. Pain 99:133-143. (Pubitemid 35247536)
132. Okamoto K, Imbe H, Tashiro A, Kumabe S, Senba E (2004). Blockade of peripheral 5HT3 receptor attenuates the formalin-induced nocifensive behavior in persistent temporomandibular joint inflammation of rat. Neurosci Lett 367:259-263. (Pubitemid 39141240)
133. Okamoto K, Imbe H, Tashiro A, Kimura A, Donishi T, Tamai Y, et al. (2005). The role of peripheral 5HT2A and 5HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation. Neuroscience 130:465-474. (Pubitemid 40125485)
134. Okazaki R, Namba H, Yoshida H, Okai H, Miura T, Kawamura M (2008). The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation. Anesth Analg 107:1064-1069.
135. Oliveras JL, Hosobuchi Y, Redjemi F, Guilbaud G, Besson JM (1977). Opiate antagonist, naloxone, strongly reduces analgesia induced by stimulation of a raphe nucleus (centralis inferior). Brain Res 120:221-229. (Pubitemid 8012037)
136. Ossipov MH, Dussor GO, Porreca F (2010). Central modulation of pain. J Clin Invest 120:3779-3787.
137. Otake T, Ieshima H, Ishida H, Ushigome Y, Saito S (1998). Bone atrophy in complex regional pain syndrome patients measured by microdensitometry. Can J Anaesth 45:831-838. (Pubitemid 29014229)
138. Palazzo E, Genovese R, Mariani L, Siniscalco D, Marabese I, De NV, et al. (2004). Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat. Eur J Pharmacol 492:169-176. (Pubitemid 38721368)
139. Parada CA, Tambeli CH, Cunha FQ, Ferreira SH (2001). The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 102:937-944. (Pubitemid 32155888)
140. Pavlakovic G, Tigges J, Crozier TA (2009). Effect of buspirone on thermal sensory and pain thresholds in human volunteers. BMC Clin Pharmacol 9:12.
141. Pertovaara A, Keski-Vakkuri U, Kalmari J, Wei H, Panula P (2001). Response properties of neurons in the rostroventromedial medulla of neuropathic rats: attempted modulation of responses by [1DMe]NPYF, a neuropeptide FF analogue. Neuroscience 105:457-468. (Pubitemid 32728128)
142. Peters CM, Hayashida K, Ewan EE, Nakajima K, Obata H, Xu Q, et al. (2010). Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat. Brain Res 1352: 83-93.
143. Pierce PA, Xie GX, Levine JD, Peroutka SJ (1996). 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 70:553-559.
144. Pierce PA, Xie GX, Meuser T, Peroutka SJ (1997). 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study. Neuroscience 81:813-819. (Pubitemid 27402525)
145. Pompeiano M, Palacios JM, Mengod G (1992). Distribution and cellular localization of messenger RNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci 12:440-453.
146. Pompeiano M, Palacios JM, Mengod G (1994). Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Mol Brain Res 23:163-178.
147. Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP Jr., Ossipov MH, et al. (2001). Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci 21: 5281-5288. (Pubitemid 32622953)
148. Porreca F, Ossipov MH, Gebhart GF (2002). Chronic pain and medullary descending facilitation. Trends Neurosci 25:319-325. (Pubitemid 34667014)
149. Rahman W, Suzuki R, Rygh LJ, Dickenson AH (2004). Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation. Neurosci Lett 361:229-231. (Pubitemid 38609258)
150. Rahman W, Suzuki R, Webber M, Hunt SP, Dickenson AH (2006). Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain 123:264-274.
151. Rahman W, Bauer CS, Bannister K, Vonsy JL, Dolphin AC, Dickenson AH (2009). Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain 5:45.
152. Richardson BP, Engel G, Donatsch P, Stadler PA (1985). Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126-131. (Pubitemid 15073674)
153. Rivot JP, Chiang CY, Besson JM (1982). Increase of serotonin metabolism within the dorsal horn of the spinal cord during nucleus raphe magnus stimulation, as revealed by in vivo electrochemical detection. Brain Res 238:117-126. (Pubitemid 12158441)
154. Rocha-Gonzalez HI, Meneses A, Carlton SM, Granados-Soto V (2005). Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Pain 117:182-192. (Pubitemid 41764786)
155. Rojas-Corrales MO, Ortega-Alvaro A, Gibert-Rahola J, Roca-Vinardell A, Micó JA (2000). Pindolol, a beta-adrenoceptor blocker/5- hydroxytryptamine1A/1B antagonist, enhances the analgesic effect of tramadol. Pain 88:119-124.
156. Rojas-Corrales MO, Berrocoso E, Micó JA (2005). Role of 5-HT1A and 5-HT1B receptors in the antinociceptive effect of tramadol. Eur J Pharmacol 511: 21-26. (Pubitemid 40380640)
157. Rueff A, Dray A (1993). Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience 54:527-535. (Pubitemid 23153761)
158. Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Javors MA, Bowden CA (1992). Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104-109.
159. Saito Y, Collins JG, Iwasaki H (1990). Tonic 5-HT modulation of spinal dorsal horn neuron activity evoked by both noxious and non-noxious stimuli: a source of neuronal plasticity. Pain 40:205-219. (Pubitemid 20070789)
160. Sasaki M, Ishizaki K, Obata H, Goto F (2001). Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 424:45-52. (Pubitemid 32695553)
161. Sasaki M, Obata H, Saito S, Goto F (2003). Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain. Anesth Analg 96:1072-1078. (Pubitemid 36359046)
162. Sasaki M, Obata H, Kawahara K, Saito S, Goto F (2006). Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain 122:130-136.
163. Shannon HE, Lutz EA (2000). Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin1A receptors. Psychopharmacology 149:93-97. (Pubitemid 30187372)
164. Silveira JW, Dias QM, Del Bel EA, Prado WA (2010). Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats. Mol Pain 6:17.
165. Skyba DA, Radhakrishnan R, Rohlwing JJ, Wright A, Sluka KA (2003). Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord. Pain 106:159-168. (Pubitemid 37329626)
166. Sommer C (2004). Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 30:117-125. (Pubitemid 41271211)
167. Sommer C (2006). Is serotonin hyperalgesic or analgesic? Curr Pain Headache Rep 10:101-106.
168. Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990). Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2:1144-1154.
169. Sounvoravong S, Nakashima MN, Wada M, Nakashima K (2004). Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. Eur J Pharmacol 484:217-223. (Pubitemid 38117213)
170. Sprouse JS, Aghajanian GK (1987). Electrophysiological responses of seroto-nergic dorsal raphé neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9. (Pubitemid 17114243)
171. Stowe RL, Barnes NM (1998). Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine. Neuropharmacology 37:1611-1619. (Pubitemid 28550435)
172. Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, et al. (1993). [Serotonin concentration in serum of patients with generalized tendomyo-pathy (fibromyalgia) and chronic polyarthritis]. Med Klin (Munich) 88: 458-462.
173. Sufka KJ, Schomburg FM, Giordano J (1992). Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 41:53-56.
174. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH (2002). Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 5:1319-1326. (Pubitemid 35417767)
175. Suzuki R, Rahman W, Hunt SP, Dickenson AH (2004a). Descending facilitatory control of mechanical evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Neuropharmacology 45: 1093-1100.
176. Suzuki R, Rygh LJ, Dickenson AH (2004b). Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25:613-617. (Pubitemid 39458166)
177. Svensson CI, Tran TK, Fitzsimmons B, Yaksh TL, Hua XY (2006). Descending serotonergic facilitation of spinal ERK activation and pain behavior. FEBS Lett 580:6629-6634. (Pubitemid 44827020)
178. Taiwo YO, Levine JD (1992). Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48:485-490.
179. Theodosiou M, Rush RA, Zhou XF, Hu D, Walker JS, Tracey DJ (1999). Hyperalgesia due to nerve damage: role of nerve growth factor. Pain 81: 245-255. (Pubitemid 29257895)
180. Thibault K, Van Steenwinckel J, Brisorgueil MJ, Fischer J, Hamon M, Calvino B, et al. (2008). Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat. Pain 140: 305-322.
181. Tuveson B, Leffler AS, Hansson P (2011). Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy Clin J Pain 27:323-329.
182. Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié M-B, et al. (1998). Design and synthesis of a series of 6-substituted-2- pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors. J Med Chem 41:5070-5083. (Pubitemid 28555464)
183. Van Steenwinckel J, Brisorgueil MJ, Fischer J, Verge D, Gingrich JA, Bourgoin S, et al. (2008). Role of spinal serotonin 5-HT2A receptor in 2′,3′-dideoxycy-tidine-induced neuropathic pain in the rat and the mouse. Pain 137:66-80. (Pubitemid 351802242)
184. Van Steenwinckel J, Noghero A, Thibault K, Brisorgueil MJ, Fischer J, Conrath M (2009). The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons in rat lumbar dorsal root ganglia. Neuroscience 161:838-846.
185. Vanderah TW (2007). Pathophysiology of pain. Med Clin North Am 91:1-12. (Pubitemid 44880052)
186. Vanegas H, Schaible HG (2004). Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 46:295-309. (Pubitemid 39574330)
187. Vera-Portocarrero LP, Zhang ET, King T, Ossipov MH, Vanderah TW, Lai J, et al. (2007). Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain 129:35-45. (Pubitemid 46551368)
188. Vergé D, Daval G, Marcinkiewicz M, Patey A, El Mestikawy S, Gozlan H, et al. (1986). Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474-3482. (Pubitemid 17208532)
189. Vergne-Salle P, Dufauret-Lombard C, Bonnet C, Simon A, Treves R, Bonnabau H, et al. (2011) A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. Eur J Pain 15:509-514.
190. Viisanen H, Pertovaara A (2010). Roles of the rostroventromedial medulla and the spinal 5-HT1A receptor in descending antinociception induced by motor cortex stimulation in the neuropathic rat. Neurosci Lett 476:133-137.
191. Vogel C, Mossner R, Gerlach M, Heinemann T, Murphy DL, Riederer P, et al. (2003). Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci 23:708-715. (Pubitemid 36139570)
192. Wang W, Wu SX, Wang YY, Liu XY, Li YQ (2003). 5-hydroxytryptamine1A receptor is involved in the bee venom induced inflammatory pain. Pain 106:135-142. (Pubitemid 37329623)
193. Wang YY, Wei YY, Huang J, Wang W, Tamamaki N, Li YQ, et al. (2009). Expression patterns of 5-HT receptor subtypes 1A and 2A on GABAergic neurons within the spinal dorsal horn of GAD67-GFP knock-in mice. J Chem Neuroanat 38:75-81.
194. Wang D, Gao Y, Ji H, Hong Y (2010). Topical and systemic administrations of ketanserin attenuate hypersensitivity and expression of CGRP in rats with spinal nerve ligation. Eur J Pharmacol 627:124-130.
195. Wei H, Pertovaara A (2006). 5-HT1A receptors in endogenous regulation of neuropathic hypersensitivity in the rat. Eur J Pharmacol 535:157-165.
196. Wei F, Dubner R, Ren K (1999). Laminar-selective noradrenergic and serotoninergic modulation includes spinoparabrachial cells after inflammation. Neuroreport 10:1757-1761. (Pubitemid 29354306)
197. Wei H, Chen Y, Hong Y (2005). The contribution of peripheral 5-hydroxytrypt-amine2A receptor to carrageenan-evoked hyperalgesia, inflammation and spinal Fos protein expression in the rat. Neuroscience 132:1073-1082. (Pubitemid 40602541)
198. Wei F, Guo W, Zou S, Ren K, Dubner R (2008). Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci 28: 10482-10495.
199. Wei F, Dubner R, Zou S, Ren K, Bai G, Wei D, et al. (2010). Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci 30:8624-8636.
200. Woolf CJ (2007). Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology 106:864-867.
201. Wu S, Zhu M, Wang W, Wang Y, Li Y, Yew DT (2001). Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation. Neurosci Lett 307:183-186. (Pubitemid 32595659)
202. Wu WP, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Koek W, Colpaert FC (2003). The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury. Eur J Pharmacol 478:131-137. (Pubitemid 37315731)
203. Wurch T, Colpaert FC, Pauwels PJ (2003). Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists. Neuropharmacology 44:873-881. (Pubitemid 36515023)
204. Xie H, Dong ZQ, Ma F, Bauer WR, Wang X, Wu GC (2008). Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats. Brain Res 1210:76-83.
205. Xu W, Qiu XC, Han JS (1994). Serotonin receptor subtypes in spinal antinociception in the rat. J Pharmacol Exp Ther 269:1182-1189. (Pubitemid 24204203)
206. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, et al. (2010). Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite, O-Desmethyltrama-dol, via activation of descending serotonergic pathways. Anesthesiology 112:696-710.
207. You HJ, Colpaert FC, Arendt-Nielsen L (2005). The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes. Exp Neurol 191:174-183. (Pubitemid 39612403)
208. Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, et al. (2002). The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 22:1010-1019. (Pubitemid 34141780)
209. Zhang YQ, Gao X, Ji GC, Wu GC (2001a). Expression of 5-HT2A receptor mRNA in rat spinal dorsal horn and some nuclei of brainstem after peripheral inflammation. Brain Res 900:146-151. (Pubitemid 32452275)
210. Zhang YQ, Yang ZL, Gao X, Wu GC (2001b). The role of 5- hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 92:201-211. (Pubitemid 32367951)
211. Zhang YQ, Gao X, Ji GC, Huang YL, Wu GC, Zhao ZQ (2002). Expression of 5-HT1A receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation. Pain 98:287-295. (Pubitemid 34786659)
212. Zhao ZQ, Chiechio S, Sun YG, Zhang KH, Zhao CS, Scott M, et al. (2007). Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 27:6045-6053. (Pubitemid 46849764)